As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
We are very excited to launch our new website! Please take a few moments to click around and explore...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...